Literature DB >> 16440581

Efficacy of imiquimod in solitary plaques of mycosis fungoides.

N Onsun1, H Ufacik, Y Kural, E Topçu, A Somay.   

Abstract

Mycosis fungoides is the most common type of cutaneous T-cell lymphoma. The extent and type of skin involvement (T classification) and presence of lymph node or visceral involvement are important predictors in selecting the type of treatment. Skin directed treatment represents the most appropriate therapy for early stage disease. Current topical treatment including potent topical steroids and nitrogen mustard are associated with adverse effects such as cutaneous atrophy and contact dermatitis. In the present study, we tested the efficacy of imiquimod in mycosis fungoides plaques.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16440581

Source DB:  PubMed          Journal:  Int J Tissue React        ISSN: 0250-0868


  3 in total

1.  Emerging treatment options for early mycosis fungoides.

Authors:  Montserrat Fernandez-Guarino
Journal:  Clin Cosmet Investig Dermatol       Date:  2013-02-18

Review 2.  Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets.

Authors:  Ieva Saulite; Wolfram Hoetzenecker; Stephan Weidinger; Antonio Cozzio; Emmanuella Guenova; Ulrike Wehkamp
Journal:  Biomed Res Int       Date:  2016-05-17       Impact factor: 3.411

3.  New Treatment Options for Mycosis Fungoides.

Authors:  Alexa Rose Shipman; Julia Scarisbrick
Journal:  Indian J Dermatol       Date:  2016 Jan-Feb       Impact factor: 1.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.